VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers (Q104788434)
Jump to navigation
Jump to search
scientific article published on 07 January 2021
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers |
scientific article published on 07 January 2021 |
Statements
VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers (English)
Hiromi Watanabe
Hiroe Kayatani
Kiichiro Ninomiya
Kazuya Nishii
Hisao Higo
Chihiro Ando
Sachi Okawa
Takamasa Nakasuka
Naofumi Hara
Atsuko Hirabae
Yuka Kato
Takashi Ninomiya
Toshio Kubo
Kammei Rai
Katsuyuki Hotta
Masahiro Tabata
Yoshinobu Maeda
Katsuyuki Kiura
7 January 2021